Skip to main content
. 2021 Mar 19;13:2681–2690. doi: 10.2147/CMAR.S301859

Table 3.

Univariate Analysis of OS and DFS

Variables OS DFS
HR (95% CI) P-value HR (95% CI) P-value
ERAS Protocol (no vs yes) 1.60(1.03,3.73) <0.001 1.34(1.27,2.60) <0.001
Age (years) 1.07(1.01,1.14) 0.030 1.10(1.03,1.18) 0.010
Gender (male) 0.63(0.38,5.15) 0.665 0.92(0.53,1.59) 0.764
Liver cirrhosis (Yes) 0.70(0.39,1.27) 0.237 0.17(0.03,1.17) 0.072
AFP (>20ng/mL) 1.69(1.13,2.53) 0.011 1.44(1.04,1.98) 0.026
Tumor encapsulation (None) 2.36(1.02,5.42) 0.044 1.55(0.90,2.67) 0.115
Tumor staging (III–IV) 1.80(1.66,3.35) 0.066 1.47(1.06,2.04) 0.022
Tumor size (>5cm) 1.39(0.72,2.70) 0.323 1.20(0.78,1.83) 0.410
Tumor number (Multiple) 1.22(0.72,2.06) 0.462 1.37(0.91,2.08) 0.132
Vascular invasion (Yes) 3.45(1.83,6.53) <0.001 2.38(1.34,4.21) 0.003
ASA (III–IV) 1.89(1.14,3.14) 0.013 2.77(1.17,6.54) 0.021
Surgical procedure (Video-assisted) 1.10(0.41,2.97) 0.845 1.34(0.52,3.41) 0.545
Blood loss (>400mL) 1.35(0.52,3.52) 0.538 1.09(0.63,1.90) 0.751
Blood transfusion (yes) 1.26(0.90,1.42) 0.234 1.45(0.82,1.62) 0.651
Postoperative complication (yes) 1.32(0.82,1.52) 0.315 1.56(0.62,1.73) 0.358
Anesthesia time (>3h) 1.39(0.66,2.93) 0.395 1.34(0.59,3.04) 0.482